SOM Biotech

SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting high safety and tolerance standards. One of our programs, for TTR Amyloidosis, after obtaining positive...

Drug reprofiling,pre-clinical validation,licensing,in silico screening,rare diseases,drug repurposing,orphan cns indications,central nervous system,intellectual property,and artificial intelligence

Som biotech operates in the Pharmaceutical manufacturing industry.

Som biotech's revenue is 11m - 100m

Som biotech has 11 - 50 employees.